Cormorant Asset Management

Cormorant Asset Management as of March 31, 2015

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 71 positions in its portfolio as reported in the March 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Receptos 9.9 $64M 390k 164.89
Alkermes (ALKS) 6.6 $43M 700k 60.97
Puma Biotechnology (PBYI) 6.1 $40M 167k 236.11
Eagle Pharmaceuticals (EGRX) 4.6 $30M 717k 41.89
Bristol Myers Squibb (BMY) 4.6 $30M 459k 64.50
Neurocrine Biosciences (NBIX) 4.4 $29M 719k 39.71
Portola Pharmaceuticals 3.4 $22M 575k 37.96
Dyax 3.0 $19M 1.1M 16.75
Sorrento Therapeutics (SRNE) 3.0 $19M 1.7M 11.56
Quotient 2.9 $19M 1.1M 17.00
Heron Therapeutics (HRTX) 2.9 $19M 1.3M 14.55
Ovascience 2.5 $16M 463k 34.73
Regulus Therapeutics 2.4 $15M 897k 16.94
Advaxis 2.2 $14M 975k 14.44
Ardelyx (ARDX) 2.0 $13M 1.0M 13.09
Tesaro 1.7 $11M 191k 57.40
Keryx Biopharmaceuticals 1.6 $11M 826k 12.73
Novavax 1.6 $10M 1.2M 8.27
Dex (DXCM) 1.5 $9.5M 153k 62.34
Karyopharm Therapeutics (KPTI) 1.4 $9.2M 301k 30.61
Alder Biopharmaceuticals 1.4 $9.2M 318k 28.86
Chimerix (CMRX) 1.3 $8.6M 230k 37.69
Omeros Corporation (OMER) 1.3 $8.6M 389k 22.03
Epirus Biopharmaceuticals In 1.2 $8.0M 897k 8.95
Pfenex 1.2 $7.6M 475k 15.94
China Biologic Products 1.1 $7.3M 77k 95.52
Agenus 1.1 $7.2M 1.4M 5.13
Forward Pharma A/s 1.1 $7.2M 255k 28.32
Sangamo Biosciences (SGMO) 1.1 $6.9M 442k 15.68
Coherus Biosciences (CHRS) 1.0 $6.7M 219k 30.58
Acceleron Pharma 1.0 $6.5M 170k 38.06
Curis 1.0 $6.3M 2.6M 2.40
Ultragenyx Pharmaceutical (RARE) 1.0 $6.3M 102k 62.09
Array BioPharma 1.0 $6.3M 850k 7.37
BioCryst Pharmaceuticals (BCRX) 0.9 $6.1M 680k 9.03
Recro Pharma 0.9 $5.9M 656k 9.07
Aptose Biosciences 0.9 $5.8M 1.1M 5.38
Kite Pharma 0.9 $5.8M 100k 57.68
Minerva Neurosciences 0.9 $5.7M 1.1M 5.00
Lion Biotechnologies 0.8 $5.1M 425k 12.11
Epizyme 0.8 $5.0M 266k 18.78
Lipocine 0.7 $4.6M 667k 6.90
Nektar Therapeutics (NKTR) 0.7 $4.4M 398k 11.00
Synageva Biopharma 0.6 $4.1M 43k 97.53
Dicerna Pharmaceuticals 0.6 $4.1M 170k 24.03
Glycomimetics (GLYC) 0.6 $3.8M 459k 8.32
Genvec 0.6 $3.7M 1.3M 2.95
Rockwell Medical Technologies 0.6 $3.7M 340k 10.93
Cerulean Pharma 0.6 $3.6M 401k 9.01
Acelrx Pharmaceuticals 0.5 $3.3M 850k 3.86
Versartis 0.5 $3.1M 170k 18.37
Nanostring Technologies (NSTGQ) 0.4 $2.8M 275k 10.19
Dermira 0.4 $2.6M 170k 15.35
Immune Design 0.4 $2.5M 119k 21.11
Kindred Biosciences 0.4 $2.3M 329k 7.14
Aquinox Pharmaceuticals 0.4 $2.3M 280k 8.22
Agile Therapeutics 0.3 $1.7M 182k 9.27
Cellectar Biosciences 0.2 $1.6M 530k 3.11
Bellicum Pharma 0.2 $1.2M 51k 23.18
Akebia Therapeutics (AKBA) 0.2 $1.1M 100k 11.11
Ascendis Pharma A S (ASND) 0.2 $1.1M 62k 17.35
Galectin Therapeutics (GALT) 0.1 $959k 286k 3.35
Veracyte (VCYT) 0.1 $984k 135k 7.28
Scynexis 0.1 $825k 99k 8.30
Cellectis S A (CLLS) 0.1 $865k 25k 34.60
Ptc Therapeutics I (PTCT) 0.1 $517k 8.5k 60.82
Applied Genetic Technol Corp C 0.1 $520k 26k 19.99
Cellectar Biosciences Inc *w exp 08/19/201 0.1 $413k 530k 0.78
Nevro (NVRO) 0.1 $407k 8.5k 47.88
Celsus Therapeutics Plc sponsored adr ne 0.0 $218k 287k 0.76
Sage Therapeutics (SAGE) 0.0 $43k 850.00 50.59